Thursday, January 11, 2018, 10:00 a.m. to 11:00 a.m. PT.
Summary from 1/11 Pacing Event: “Gaining Buy-in for Preventing Adverse Drug Events Related to Hypoglycemic Agents”
This two-part Pacing Event series, which will continue on January 18th, focused on a commonly-reported barrier to progress on adverse drug events (ADEs) by HIINs: hospital-level leadership buy-in. To address this barrier, this two-part webinar series features national-level subject matter experts and thought leaders who are providing information about the prevalence of and cost associated with each ADE category, and then discussing where to start in driving improvements, including the need for measures that are meaningful to hospital and physician leaders in an effort to secure support and necessary resources.
The session focused specifically on ADEs associated with hypoglycemic agents with presentations from:
- CAPT Dan S. Budnitz, MD, MPH, Director of the CDC’s Medication Safety Program, who framed the session by presenting data that highlights the prevalence of ADEs and their cost to hospitals, as well as discussed the challenges that hospitals face in measuring and reporting ADEs; and
- Gregory Maynard, MD, MS, MHM, from the UC Davis Medical Center, who focused on hypoglycemia as an important preventable ADE, and discussed strategies and resources for preventing hypoglycemia, as well as recommendations related to meaningful measures to help track this ADE.
To view and download slides and recording from this Pacing Event, click here. We encourage you to review the resources referenced in this presentation, some of which are listed below: